PROC News and Press, Procaps Group S.A. From 11/13/23

INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...

Company to Host Conference Call on Thursday November 16, 2023 at 10:30 a.m. Eastern Time Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical services company, announced it will report its results for the third quarter and ...

Procaps Ranked First Among Companies in the Pharmaceutical Segment in Colombia for the 5 th Consecutive Year Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced today that the National Business Asso...

2023-10-25 13:11:55 ET Gainers: Abri SPAC I ( ASPA ) +154% . Jaguar Global Growth Corp I ( JGGC ) +88% . Nuvve Holding Corp ( NVVE ) +44% . Data Knights Acquisition Corp ( DKDCA ) +42% . Werewolf Therapeutics ( HOWL ) +28% . ...

Experienced Pharma Professional Brings Wealth of International Industry and Governance Experience to Board Procaps Group (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced the ap...

Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced today that it will participate at the CPHI Barcelona 2023, that will take place from October 24 th to October 26 th , continuing with our two-decade pre...

The Webinar will occur on Tuesday, October 10, 2023 at 10:00 a.m. Eastern Time Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical services company, announced that it will host a webinar dedicated to the Colombian pharma marke...

Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, announced today that members of its executive leadership team will participate at two upcoming investor conferences. On Octob...

The Agreement Substantially Increases Procaps' Participation in the Oncology Market in the LatAm Region Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, announced today...

2023-09-05 13:19:05 ET Procaps Group S.A. (PROC) Q2 2023 Earnings Call Transcript September 5, 2023, 11:00 AM ET Company Participants Melissa Angelini - IR Director Ruben Minski - CEO Patricio Vargas - CFO Conference Call Participants Kemp Doliver - B...